Skip to main content
Premium Trial:

Request an Annual Quote

Incubator New Virginia Center Says Ha! to Market Slowdown

Premium

Given the state of the economy and proximity of Maryland’s biotech corridor, Fairfax County Economic Development Authority’s new incubator in northern Virginia faces an inauspicious future. But the FCEDA is confident that its 7,000-square-foot Bioinformatics Center, launched and managed by UK-based Angle Technology, will succeed.

“Bioinformatics will remain an important component of the drug development and healthcare industries, even though some bioinformatics companies are currently undergoing significant challenges to their business models,” says Gary Evans, CEO of Angle.

“And what’s really driven the growth of our economy over the last decade,” says Gerald Gordon, FCEDA’s president and CEO, “has been the information technology sector.”

Gordon sees opportunities arising from existing scientific resources in the area. “We have NIH just over the Potomac River. We have all this science that has grown up in Montgomery County. We have all the IT support here. And that marriage gives us a great opportunity to attract these companies,” Gordon says.

The FCEDA also hopes to house companies it helped create in the incubator, slated to open by this month. It originally chose the Springfield location because of Northern Virginia Community College’s new medical complex there. NVCC, along with George Mason University, Virginia Commonwealth University School of Medicine, and Inova Health System have partnered with the FCEDA.

The collaboration has produced a variety of educational opportunities in medicine and medical technologies, all based in Springfield. Any company generated from this brainpower can be incubated in the Bioinformatics Center and may then return to the schools to train and hire employees. “You can go from the cradle to the grave, in terms of corporations and career, all right there,” Gordon says.

— Diana Jong

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.